ARCHIVES

NCI Advisors Set SPORE Review Criteria, Approve Plan To Fund New Ovarian Grant

This article is from The Cancer Letter archive.

Vol. 24 No. 25 | June 26, 1998

Download PDF Visit The Full Archive

Related Articles

NCAB Opposes Line Item for Centers

May 23, 1980

Drug Discovery Group Announcement Issued

January 7, 1983

FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says.

January 14, 2005

Loss Of Core Grants Imperials Status Of Three Comprehensive Cancer Centers

July 14, 1989

“Miracle-Gro for Cancer?” ODAC Members Vent At Amgen And J&J Over Claims, Advertising.

May 18, 2007

Jury Finds USC Geneticist William French Anderson Guilty of Sexual Abuse of a Child.

July 28, 2006